--- title: "Supply and Support of Complete Antibody Quantification Testing Systems" ocid: "ocds-h6vhtk-04fb3d" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04fb3d" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04fb3d.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04fb3d.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "NHS BLOOD AND TRANSPLANT" published: "2025-04-01" --- # Supply and Support of Complete Antibody Quantification Testing Systems Buyer: NHS BLOOD AND TRANSPLANT Current stage: Planning OCID: ocds-h6vhtk-04fb3d [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04fb3d) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04fb3d.json) ## Summary NHS Blood and Transplant (NHSBT) has initiated the planning stage for the procurement of the "Supply and Support of Complete Antibody Quantification Testing Systems" for their Red Cell Immunohaematology (RCI) function. This early market engagement aims to connect with suppliers capable of providing quantification methods for anti-D and anti-c antibodies, which are critical for assessing alloimmunisation levels and supporting the clinical management of ANC patients. The procurement process is currently in the planning stage, with a market engagement exercise scheduled for the week of 19th May 2025. Interested suppliers must express their interest by 2nd May 2025. The engagement meetings will be held remotely, primarily focusing on suppliers offering medical consumables and meeting specific quality requirements. The procurement process will formally begin later, with NHSBT aiming to gather insights to shape their procurement strategy for the anticipated contract start on 11th May 2026. This tender offers significant opportunities for businesses, particularly those specialising in medical consumables and antibody quantification systems. With an estimated value of £1,200,000 and potential renewals, the contract could substantially benefit suppliers capable of delivering high-quality, reliable testing systems. SMEs are encouraged to participate, as the NHSBT is particularly interested in engaging flexible and innovative suppliers who can meet the 24-hour turnaround time and adhere to CE marking standards. This tender is well-suited for companies with a robust track record in medical diagnostics, particularly those interested in expanding their presence in the healthcare procurement market. ## Notice Anti-D and Anti-c Antibody Quantification NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to engage with suppliers of red cell antibody quantification methods via an early market engagement exercise. Please note this is not the start of a procurement process; a separate contract notice will be published to cover this requirement. Prior to commencing the formal procurement process, NHSBT would like to consult the market to improve our knowledge of all current offers available, identify further opportunities and potential issues, as well as gauge market interest in the proposed service. This engagement will help shape NHSBT procurement strategy. The RCI laboratories in NHSBT provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients' by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig This specialised test conducted in 4 of the 7 RCI laboratories (namely Birmingham, Colindale, Liverpool and Newcastle). RCI processes approximately 10,000 tests annually. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals. NHSBT is seeking to engage with suppliers on the market who can provide Antibody Quantification. The requirement is likely to include the following: * Quantification of anti-D and anti-c (expressed in IU/mL). * Less than 24-hour TAT * Quality requirements (such as CE marked) As part of the early market engagement exercise, NHSBT would like to discuss our requirement with suppliers along with a time frame for supply. ### Planning Information It is our intention to hold the early market engagement exercise supplier meetings the week of 19th May 2025. The meetings will be held remotely. To enable us to finalise arrangements (e.g. send meeting details and agree time slots), interested organisations are required to send an expression of interest via email to coco.otiotio@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on Friday 2nd May. This should include a list of your requested attendees and a brief overview (or a website link) of the Goods / Services which might be of interest to us in relation to this requirement. Please include options, if available, for a managed service contract. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/012221-2025 | | Notice type | UK2 - Preliminary Market Engagement Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | SME | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 1 Apr 2025 | | Submission deadline | Not specified | | Future notice date | 3 Nov 2025 | | Award date | Not specified | | Contract period | 10 May 2026 - 11 May 2033 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £1,200,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planning | | Lots status | Planning | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS BLOOD AND TRANSPLANT | | Locality | BRISTOL | | Post town | Bristol | | Postcode | BS34 7QH | | Country | England | | ITL 1 | TLK South West (England) | | ITL 2 | TLK5 West of England | | ITL 3 | TLK52 Bath & North East Somerset and South Gloucestershire | | Local authority | South Gloucestershire | | Electoral ward | Filton | | Westminster constituency | Filton and Bradley Stoke | | Delivery location | TLG31 Birmingham, TLI London, TLK11 Bristol, City of | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33140000 - Medical consumables ## Release History - 1 Apr 2025 at 11:31 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/012221-2025 ## Documents - https://www.find-tender.service.gov.uk/Notice/012221-2025 1st April 2025 - Preliminary market engagement notice on Find a Tender ## Notice URLs - https://www.legislation.gov.uk/ukpga/2023/54/contents - https://www.nhsbt.nhs.uk/ ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04fb3d. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04fb3d.json.